HIV-1 uncoats in the nucleus near sites of integration.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
10 03 2020
Historique:
pubmed: 26 2 2020
medline: 14 7 2020
entrez: 26 2 2020
Statut: ppublish

Résumé

HIV-1 capsid core disassembly (uncoating) must occur before integration of viral genomic DNA into the host chromosomes, yet remarkably, the timing and cellular location of uncoating is unknown. Previous studies have proposed that intact viral cores are too large to fit through nuclear pores and uncoating occurs in the cytoplasm in coordination with reverse transcription or at the nuclear envelope during nuclear import. The capsid protein (CA) content of the infectious viral cores is not well defined because methods for directly labeling and quantifying the CA in viral cores have been unavailable. In addition, it has been difficult to identify the infectious virions because only one of ∼50 virions in infected cells leads to productive infection. Here, we developed methods to analyze HIV-1 uncoating by direct labeling of CA with GFP and to identify infectious virions by tracking viral cores in living infected cells through viral DNA integration and proviral DNA transcription. Astonishingly, our results show that intact (or nearly intact) viral cores enter the nucleus through a mechanism involving interactions with host protein cleavage and polyadenylation specificity factor 6 (CPSF6), complete reverse transcription in the nucleus before uncoating, and uncoat <1.5 h before integration near (<1.5 μm) their genomic integration sites. These results fundamentally change our current understanding of HIV-1 postentry replication events including mechanisms of nuclear import, uncoating, reverse transcription, integration, and evasion of innate immunity.

Identifiants

pubmed: 32094182
pii: 1920631117
doi: 10.1073/pnas.1920631117
pmc: PMC7071919
doi:

Substances chimiques

Capsid Proteins 0
cleavage factor Im, human 0
mRNA Cleavage and Polyadenylation Factors 0
Green Fluorescent Proteins 147336-22-9

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

5486-5493

Informations de copyright

Copyright © 2020 the Author(s). Published by PNAS.

Références

Nat Microbiol. 2019 Nov;4(11):1840-1850
pubmed: 31611641
Cell Host Microbe. 2018 Apr 11;23(4):536-548.e6
pubmed: 29649444
J Virol. 2007 Nov;81(22):12596-607
pubmed: 17728233
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E1054-63
pubmed: 26858452
J Virol. 2015 May;89(10):5350-61
pubmed: 25741002
PLoS Pathog. 2017 Jul 20;13(7):e1006460
pubmed: 28727807
J Virol. 2004 Oct;78(19):10803-13
pubmed: 15367647
PLoS Pathog. 2016 Jun 20;12(6):e1005709
pubmed: 27322072
J Biol Chem. 2015 Oct 30;290(44):26412-21
pubmed: 26354430
Elife. 2019 Jan 23;8:
pubmed: 30672737
Nat Rev Microbiol. 2015 Aug;13(8):471-83
pubmed: 26179359
Proc Natl Acad Sci U S A. 2017 Aug 22;114(34):E7169-E7178
pubmed: 28784755
Mol Cell Biol. 1991 Mar;11(3):1419-30
pubmed: 1847499
Retrovirology. 2013 Jul 09;10:70
pubmed: 23835323
Cell Rep. 2015 Nov 24;13(8):1717-31
pubmed: 26586435
Proc Natl Acad Sci U S A. 2009 Aug 11;106(32):13535-40
pubmed: 19628694
EMBO J. 2003 Apr 1;22(7):1707-15
pubmed: 12660176
Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5636-41
pubmed: 23513220
Cell Host Microbe. 2010 Mar 18;7(3):221-33
pubmed: 20227665
J Virol. 2013 Jan;87(1):683-7
pubmed: 23077298
Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9975-80
pubmed: 21628558
Elife. 2014 Dec 17;3:e04114
pubmed: 25517934
J Virol. 2014 Dec;88(23):13613-25
pubmed: 25231297
Nature. 2018 Dec;564(7735):278-282
pubmed: 30487602
PLoS Pathog. 2017 Aug 21;13(8):e1006570
pubmed: 28827840
EMBO J. 2007 Jun 20;26(12):3025-37
pubmed: 17557080
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):E4780-9
pubmed: 24248339
Nature. 2016 Aug 18;536(7616):349-53
pubmed: 27509857
J Cell Biol. 2008 Feb 11;180(3):549-61
pubmed: 18250195
Cell. 2016 Mar 10;164(6):1162-1171
pubmed: 26967283
Cell. 2019 Mar 7;176(6):1502-1515.e10
pubmed: 30799036
Elife. 2018 Jun 07;7:
pubmed: 29877795
PLoS Pathog. 2011 Mar;7(3):e1001313
pubmed: 21423673
Nat Rev Microbiol. 2017 Feb;15(2):69-82
pubmed: 27941817
J Virol. 1979 Apr;30(1):32-7
pubmed: 90159
Nature. 2013 Nov 21;503(7476):402-405
pubmed: 24196705
Science. 2016 Dec 16;354(6318):1434-1437
pubmed: 27980210
Retrovirology. 2016 Aug 22;13(1):58
pubmed: 27549239
J Virol. 2014 Jun;88(12):7054-69
pubmed: 24672043
Nature. 2015 May 14;521(7551):227-31
pubmed: 25731161
Nature. 2013 May 30;497(7451):643-6
pubmed: 23719463
PLoS Pathog. 2011 Aug;7(8):e1002194
pubmed: 21901095
PLoS Pathog. 2011 Dec;7(12):e1002439
pubmed: 22174692
Methods Mol Biol. 2014;1087:29-36
pubmed: 24158811
Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6125-9
pubmed: 7687060
Science. 2014 Jan 24;343(6169):428-32
pubmed: 24356113
AIDS Res Hum Retroviruses. 1994 Jan;10(1):53-9
pubmed: 8179964
Virology. 2014 Apr;454-455:371-9
pubmed: 24559861
J Virol. 2016 Jul 11;90(15):6918-6935
pubmed: 27307565
Cell Host Microbe. 2018 Sep 12;24(3):392-404.e8
pubmed: 30173955
Science. 2015 Jul 3;349(6243):99-103
pubmed: 26044298

Auteurs

Ryan C Burdick (RC)

Viral Mutation Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702.

Chenglei Li (C)

Viral Mutation Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702.

MohamedHusen Munshi (M)

Viral Mutation Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702.

Jonathan M O Rawson (JMO)

Viral Recombination Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702.

Kunio Nagashima (K)

Electron Microscopy Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD 21702.

Wei-Shau Hu (WS)

Viral Recombination Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702.

Vinay K Pathak (VK)

Viral Mutation Section, HIV Dynamics and Replication Program, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD 21702; pathakv@mail.nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH